STANDARD BIOTOOLS INC. - COMMON STOCK

Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

21 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

17 Mar 2022 17:58:32 By Nasdaq GlobeNewswire

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 

17 Feb 2022 17:43:00 By Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

17 Feb 2022 08:30:01 By Nasdaq GlobeNewswire

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

14 Feb 2022 06:10:00 By Nasdaq GlobeNewswire

Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.

24 Jan 2022 08:30:01 By Nasdaq GlobeNewswire

Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021

11 Jan 2022 08:00:01 By Nasdaq GlobeNewswire

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

07 Dec 2021 08:30:00 By Nasdaq GlobeNewswire

Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

16 Nov 2021 08:30:00 By Nasdaq GlobeNewswire

Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost

11 Nov 2021 08:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces Third Quarter 2021 Financial Results

08 Nov 2021 16:02:00 By Nasdaq GlobeNewswire

Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer

08 Nov 2021 08:30:01 By Nasdaq GlobeNewswire

Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results

20 Oct 2021 08:30:00 By Nasdaq GlobeNewswire

Fluidigm 2021 IMC Summit Focuses on ‘Uncovering Spatial Biology’

18 Oct 2021 08:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software

12 Oct 2021 08:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT

28 Sep 2021 08:30:00 By Nasdaq GlobeNewswire

Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference

02 Sep 2021 08:30:00 By Nasdaq GlobeNewswire

CyTOF and Maxpar Direct Technologies Utilized in Study Characterizing Immune and Inflammatory Responses in Pregnant Women Infected with SARS-CoV-2

31 Aug 2021 08:30:00 By Nasdaq GlobeNewswire

Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit

09 Aug 2021 11:14:28 By Nasdaq GlobeNewswire

Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million

05 Aug 2021 16:05:01 By Nasdaq GlobeNewswire